Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
231 USD | -1.36% | -4.20% | +13.56% |
Apr. 19 | RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target | MT |
Apr. 18 | Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.56% | 7.1B | C | ||
+12.59% | 128B | A- | ||
-10.58% | 10.66B | A- | ||
-0.39% | 8.55B | C | ||
+25.94% | 5.06B | B+ | ||
+6.93% | 3.4B | C- | ||
-1.64% | 3.08B | B- | ||
-11.96% | 2.11B | - | - | |
-7.25% | 2.03B | - | ||
-25.23% | 1.69B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- INSP Stock
- Ratings Inspire Medical Systems, Inc.